Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.29514?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=083122
Telehealth Services, Medications for Opioid Use Disorder, Overdose Among Medicare Beneficiaries Before, During COVID-19
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2022.2284?guestAccessKey=ee7219e9-7be8-4f85-bf27-6313250cfea3&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=083122
Genetic Spectrum of Uncombable Hair Syndrome
JAMA Dermatology
EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, AUGUST 31, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2022.2319?guestAccessKey=26fe63b7-c8fa-41f1-b2f2-65fba9448ac2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=083122
About The Study: Researchers conducted a genetic analysis of individuals with uncombable hair syndrome, a rare hair shaft anomaly that is characterized by dry, frizzy and wiry hair that cannot be combed flat. Only about 100 known cases have been reported so far.
Authors: Regina C. Betz, M.D., of the University of Bonn in Bonn, Germany, is the corresponding author.
(doi:10.1001/jamadermatol.2022.2319)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Maternal Mental Health, Infant Development During Pandemic
JAMA Psychiatry
EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, AUGUST 31, 2022
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2022.2591?guestAccessKey=ee24b3f1-a54f-420d-be90-5ebf0b7e039e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=083122
About The Study: This article provides an overview of the current understanding of associations between the COVID-19 pandemic and mental health among pregnant and postpartum women and infant behavioral development.
Authors: Catherine Monk, Ph.D., of Columbia University in New York, is the corresponding author.
(10.1001/jamapsychiatry.2022.2591)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Clinical, Virological Characteristics of SARS-CoV-2 Infection in Young Children
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, AUGUST 31, 2022
Media advisory: The full study and commentary are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.27348?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=083122
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: In this study involving 690 participants from 175 households, SARS-CoV-2 infections were frequently asymptomatic in children age 4 and younger. The presence and number of symptoms did not correlate with viral load. These findings suggest that symptom screening may be insufficient to prevent outbreaks involving young children.
Authors: Ruth A. Karron, M.D., of Johns Hopkins University in Baltimore, is the corresponding author.
(doi:10.1001/jamanetworkopen.2022.27348)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Visual Abstract: Effects of Exercise Program on Brain Health Outcomes for Children With Overweight or Obesity
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, AUGUST 30, 2022
Media advisory: The full study is linked to this news release. A visual abstract is below.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.27893?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=083022
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
Visual Abstract
Authors: Francisco B. Ortega, Ph.D., of the University of Granada in Granada, Spain, is the corresponding author.
(doi:10.1001/jamanetworkopen.2022.27893)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Abusive Head Trauma in Infants During COVID-19 in Paris Metropolitan Area
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, AUGUST 30, 2022
Media advisory: The full study and commentary are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.26182?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=083022
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: Researchers found a marked increase in the incidence and severity of abusive head trauma in infants during the COVID-19 pandemic period in the Paris metropolitan area compared with the pre-pandemic period. Although the containment and mitigation measures were necessary to reduce the spread of COVID-19, they may have had unintended health consequences for children, such as an increase in abusive head trauma. These results suggest the need for clinical awareness and preventive actions.
Authors: Flora Blangis, M.P.H., of the Universite Paris Cite in Paris, is the corresponding author.
(doi:10.1001/jamanetworkopen.2022.26182)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Domestic Violence Consultations in Japan Before vs During Pandemic
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, AUGUST 30, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.29421?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=083022
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: This study found that rates of help-seeking consultations for domestic violence increased during the COVID-19 pandemic in Japan. This increase may be associated with a range of factors, including economic instability, increased exposure to exploitative relationships, and reduced support options.
Authors: Xerxes T. Seposo, Ph.D., M.P.H., of Hokkaido University in Sapporo, Japan, is the corresponding author.
(doi:10.1001/jamanetworkopen.2022.29421)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Visual Abstract: Efficacy, Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy
JAMA Neurology
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, AUGUST 29, 2022
Media advisory: The full study is linked to this news release. A visual abstract is below.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2022.2480?guestAccessKey=9ed5d243-d7ec-43eb-9df6-d95d4b6e1c69&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082922
Visual Abstract
Authors: Eric P. Hoffman, Ph.D., of School of Pharmacy and Pharmaceutical Sciences Binghamton University—State University of New York in Binghamton, is the corresponding author.
(doi:10.1001/jamaneurol.2022.2480)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Visual Abstract: Improving Antibiotic Stewardship for Diarrheal Disease With Probability-Based Electronic Clinical Decision Support
JAMA Pediatrics
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, AUGUST 29, 2022
Media advisory: The full study is linked to this news release. A visual abstract is below.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2022.2535?guestAccessKey=9ef9098c-a014-470b-9b24-fe8938b82ed9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082922
Visual Abstract
Authors: Eric J. Nelson, M.D., Ph.D., of the University of Florida in Gainesville, and Daniel T. Leung, M.D., M.Sc., of the University of Utah School of Medicine in Salt Lake City, are the corresponding authors.
(doi:10.1001/jamapediatrics.2022.2535)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Comparison of SARS-CoV-2 Results in Self-Collected vs Health Care Worker–Collected Nasal Swabs in Children, Adolescents
JAMA
EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, AUGUST 26, 2022
Media advisory: The full study and editorial are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.14877?guestAccessKey=d98d9357-ab4b-477a-b97c-ae5c9382870c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082622
About The Study: After hearing and seeing simple instructional materials, children and adolescents ages 4 to 14 self-collected nasal swabs that closely agreed on SARS-CoV-2 detection with swabs collected by health care workers.
Authors: Wilbur A. Lam, M.D., Ph.D., and Greg S. Martin, M.D., M.Sc., of the Emory University School of Medicine in Atlanta, are the corresponding authors.
(doi:10.1001/jama.2022.14877)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Analysis of Neutralizing Antibody Levels in Children, Adolescents After SARS-CoV-2 Infection
JAMA Pediatrics
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, AUGUST 29, 2022
Media advisory: The full study and editorial are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2022.3072?guestAccessKey=9d515e08-5df1-4b6e-ab4a-9b947b1d429c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082922
About The Study: This study assessed the presence of neutralizing antibodies in blood samples of children in different age groups up to 16 months after SARS-CoV-2 infection.
Authors: Chee Fu Yung, M.B.Ch.B., of the KK Women’s and Children’s Hospital in Singapore, is the corresponding author.
(doi:10.1001/jamapediatrics.2022.3072)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Association of Pandemic With Medical School Diversity Programs
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, AUGUST 29, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.29086?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082922
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: The findings of this survey study suggest that medical school programs designed to increase the diversity of the physician workforce were disrupted by the COVID-19 pandemic. The long-term outcomes of these disruptions are unknown.
Authors: Sonal Batra, M.D., M.S.T., of George Washington University in Washington, D.C., is the corresponding author.
(doi:10.1001/jamanetworkopen.2022.29086)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Administration of Anti–SARS-CoV-2 Monoclonal Antibodies After FDA Deauthorization
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, AUGUST 29, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.28997?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082922
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: Hospitals and health systems administered more than 158,000 anti–SARS-CoV-2 monoclonal antibodies (mAbs) doses in early 2022 despite Food and Drug Administration (FDA) deauthorization because of a lack of efficacy against the Omicron variant. Medicare payments for mAb administration range from $450 to $750 per dose, indicating that spending on these deauthorized treatments likely exceeds $71 million. The findings suggest that the use of deauthorized mAb products was widespread, even though patients had a minimal likelihood of benefit.
Authors: Timothy S. Anderson, M.D., M.A.S., of Beth Israel Deaconess Medical Center in Boston, is the corresponding author.
(doi:10.1001/jamanetworkopen.2022.28997)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Use of Digital Platform to Report COVID-19 Self-Test Results to Health Departments
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, AUGUST 26, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.28885?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082622
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: The results of this study of 14,000 household beneficiaries of a COVID-19 test kit program in six communities suggest that application-based reporting with incentives may be associated with increased reporting of rapid tests for COVID-19. However, increasing its use may be a critical first step.
Authors: Apurv Soni, M.D., Ph.D., of the University of Massachusetts Chan Medical School in Worcester, is the corresponding author.
(doi:10.1001/jamanetworkopen.2022.28885)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
COVID-19 Incidence, Severity Among Adults Vaccinated With, Without Boosters in Singapore
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, AUGUST 26, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.28900?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082622
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: This study of 2.4 million adults in Singapore investigated levels of protection against severe COVID-19 and confirmed SARS-CoV-2 infection across several vaccine types, vaccine combinations and time since last dose.
Authors: Oon Tek Ng, M.R.C.P., of the National Centre for Infectious Diseases in Singapore, is the corresponding author.
(doi:10.1001/jamanetworkopen.2022.28900)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Association Between Medicaid Managed Care Coverage of Substance Use Services, Treatment Use
JAMA Health Forum
EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, AUGUST 26, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.2812?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082622
About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.
About The Study: Researchers examined the association between changes in Medicaid managed care coverage of substance use services and admissions for substance use treatment in Maryland and Nebraska from 2010 to 2019.
Authors: Samantha G. Auty, M.S., of the Boston University School of Public Health, is the corresponding author.
(doi:10.1001/jamahealthforum.2022.2812)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Association of Medicare Advantage Premiums With Measures of Quality, Patient Experience
JAMA Health Forum
EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, AUGUST 26, 2022
Media advisory: The full study and editorial are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.2826?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082622
About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.
About The Study: The findings of this analysis suggest that although there were modest improvements in the average quality of care offered by high-premium Medicare Advantage plans, plans with high quality of care are available at every premium level.
Authors: Marc N. Elliott, Ph.D., of the RAND Corporation in Santa Monica, California, is the corresponding author.
(doi:10.1001/jamahealthforum.2022.2826)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Geographic Variation in Appointment Wait Times for US Military Veterans
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.28783?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082522
Association of COVID-19 Infection With Wearing Glasses in a High-Prevalence Area in Denmark and Sweden
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2022.3234?guestAccessKey=7d56433d-f458-4ca2-b4f1-97804445be00&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082522
Monkeypox Infection
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2022.3975?guestAccessKey=2cf10798-319d-4c45-a50c-da71b1194407&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082522
Relapse Rates and Disease-Specific Mortality Following Procedures for Fertility Preservation at Time of Breast Cancer Diagnosis
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.3677?guestAccessKey=14d8ef3b-d59d-4322-aee4-d8ef1be7480d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082522
Missed Opportunities and Health Disparities for Advance Care Planning Before Elective Surgery in Older Adults
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2022.3687?guestAccessKey=1c53c68b-501a-40bf-95fc-9a885c656de1&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082422
Association Between Geospatial Access to Care and Firearm Injury Mortality in Philadelphia
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2022.3677?guestAccessKey=66837b8e-24f0-457f-965f-7cca4bcc77f8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082422
Reporting of Race and Hispanic Ethnicity in Breast Cancer Studies From the National Cancer Database
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.3527?guestAccessKey=df819b8f-2bea-41e3-a44d-a56c120be434&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082522
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2022.2096?guestAccessKey=e1328a7a-6e79-43f8-ad04-143fd8134839&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082422
Association Between Changes in Alcohol Consumption and Cancer Risk
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.28544?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082422
Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.28588?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082422
Association of Leisure Time Physical Activity Types and Risks of All-Cause, Cardiovascular, and Cancer Mortality Among Older Adults
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.28510?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082422
Accuracy of 2 Rapid Antigen Tests During 3 Phases of SARS-CoV-2 Variants
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.28143?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082422
Content Analysis of the Corporate Social Responsibility Practices of 9 Major Cannabis Companies in Canada and the US
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.28088?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082322
Presence and Comprehensiveness of Antibullying Policies for Faculty at US Medical Schools
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.28673?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082322
Outcomes and Safety of Very-Low-Dose Edoxaban in Frail Patients With Atrial Fibrillation in the ELDERCARE-AF Randomized Clinical Trial
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.28500?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082322
Evaluation of Spending Differences Between Beneficiaries in Medicare Advantage and the Medicare Shared Savings Program
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.28529?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082322
Visual Abstract: Effect of Azithromycin Treatment to Preschool-Age Children on Trachoma Prevalence in Niger
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, AUGUST 23, 2022
Media advisory: The full study is linked to this news release. A visual abstract is below.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.28244?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082322
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
Visual Abstract
Authors: Jeremy D. Keenan, M.D., M.P.H., of the University of California, San Francisco, is the corresponding author.
(doi:10.1001/jamanetworkopen.2022.28244)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Visual Abstract: Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Replacement
JAMA
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, AUGUST 23, 2022
Media advisory: The full study and editorial are linked to this news release. A visual abstract is below.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.13416?guestAccessKey=62ec1f84-1cf8-4fc2-b40e-dae49589eb3b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082322
Visual Abstract
Authors: Verinder S. Sidhu, M.S., of the Ingham Institute for Applied Medical Research in Liverpool, Australia, is the corresponding author.
(doi:10.1001/jama.2022.13416)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Visual Abstract: Radiotherapy With vs Without Chemoradiotherapy, Survival Without Disease Relapse in Low-risk Nasopharyngeal Carcinoma
JAMA
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, AUGUST 23, 2022
Media advisory: The full study is linked to this news release. A visual abstract is below.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.13997?guestAccessKey=dce288b8-286c-4062-8bd6-49206e468806&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082322
Visual Abstract
Authors: Jun Ma, M.D., of Sun Yat-sen University Cancer Center in Guangzhou, China, is the corresponding author.
(doi:10.1001/jama.2022.13997)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
COVID-19 Disease Severity With Omicron Sublineages, Vaccination Status
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2022.3351?guestAccessKey=c3d7dbab-fe64-4d08-bd10-cd1d421972c9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082222
Association of Fatal Overdose Notification Letters With Prescription of Benzodiazepines
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2022.3372?guestAccessKey=e837f041-62d7-4699-b157-c572ad69312c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082222
Long-term Outcomes of Childhood Family Income Supplements on Adult Functioning
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2022.2946?guestAccessKey=c9f1ed42-ba06-4ed3-afe0-53e814d9d215&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082222
Utility of Newborn Dried Blood Spots to Ascertain Seroprevalence of SARS-CoV-2 Antibodies
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.27995?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082222
COVID-19 Vaccine Willingness Among Health Care Workers in Southeast Asia
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.28061?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082222
SARS-CoV-2 Load in Wastewater, COVID-19 Cases in Tokyo Olympic, Paralympic Village
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.26822?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082222
USPSTF Recommendation on Statin Use for Primary Prevention of Cardiovascular Disease
JAMA
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, AUGUST 23, 2022
Media advisory: To contact the U.S. Preventive Services Task Force, email the Media Coordinator at Newsroom@USPSTF.net or call 301-951-9203. The full report and related articles are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time and all USPSTF articles remain free indefinitely https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.13044?guestAccessKey=1abe13bf-c396-4e82-b61e-cc0aa85cdd49&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082322
Bottom Line: The U.S. Preventive Services Task Force (USPSTF) recommends that for primary prevention of cardiovascular disease (CVD) in adults ages 40 to 75 who have one or more CVD risk factors (i.e., dyslipidemia, diabetes, hypertension, or smoking), clinicians should prescribe a statin for those with an estimated 10-year CVD risk of 10% or greater and selectively offer a statin for those with an estimated risk of 7.5% to less than 10%. The USPSTF concludes that the current evidence is insufficient to make a recommendation about initiating a statin for the primary prevention of CVD events and mortality in adults age 76 or older. Cardiovascular disease is the leading cause of death in the United States, the cause of more than 1 of every 4 deaths. The USPSTF routinely makes recommendations about the effectiveness of preventive care services, and this recommendation replaces and is generally consistent with its 2016 recommendation.
(doi:10.1001/jama.2022.13044)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Note: More information about the U.S. Preventive Services Task Force, its process, and its recommendations can be found on the newsroom page of its website.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.
Examining Association of Chronic Disease With Financial Outcomes of Patients
JAMA Internal Medicine
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, AUGUST 22, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2022.3687?guestAccessKey=f5ca82da-d842-428d-8e13-4e3a431f54af&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082222
About The Study: This study of 2.8 million commercially insured adults found an association between chronic disease diagnoses and adverse credit report outcomes, with increasing rates of medical debt in collections, nonmedical debt in collections, total delinquent debt, low credit score and recent bankruptcy as an individual’s number of chronic conditions increased.
Authors: Nora V. Becker, M.D., Ph.D., of the University of Michigan in Ann Arbor, is the corresponding author.
(doi:10.1001/jamainternmed.2022.3687)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Symptoms, Health Conditions in Children Following SARS-CoV-2 Infection
JAMA Pediatrics
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, AUGUST 22, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2022.2800?guestAccessKey=f8454215-bfaa-487e-b4e4-5f0a3f8405c9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082222
About The Study: This study of nearly 660,000 children who were tested for SARS-CoV-2 by antigen or polymerase chain reaction examined the symptoms, diagnosed health conditions and medications associated with SARS-CoV-2 infection four weeks or more following the initial test.
Authors: Suchitra Rao, M.B.B.S., M.S.C.S., of the University of Colorado School of Medicine and Children’s Hospital Colorado in Aurora, is the corresponding author.
(doi:10.1001/jamapediatrics.2022.2800)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Incubation Period of COVID-19 Caused by Different SARS-CoV-2 Strains
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, AUGUST 22, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.28008?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082222
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: The findings of this systematic review and meta-analysis of 141 articles suggest that with the evolution of mutant strains, the incubation period of COVID-19 decreased gradually from Alpha (5 days) to Omicron variant (3.42 days). Identifying the incubation period of different variants is a key factor in determining the isolation period.
Authors: Min Liu, Ph.D., of Peking University in Beijing, and Wannian Liang, Ph.D., of Tsinghua University in Beijing, are the corresponding authors.
(doi:10.1001/jamanetworkopen.2022.28008)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Therapeutic Value of Drugs Granted Accelerated Approval or Conditional Marketing Authorization
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.2685?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081922
About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.
Variations in Uptake of COVID-19 Booster Doses Among Fully Vaccinated Adults
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, AUGUST 19, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.27680?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081922
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: In this survey study of 135,000 adults, less than half (48.5%) of individuals who had been fully vaccinated nationwide had received a booster dose. Marked variations were seen across geographic locations, occupation types, and other sociodemographic characteristics. Targeted efforts at populations with low uptake may be needed to improve booster vaccine coverage.
Authors: Israel T. Agaku D.M.D., M.P.H., M.B.A., Ph.D., of NYC Health + Hospitals in New York, is the corresponding author.
(doi:10.1001/jamanetworkopen.2022.27680)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Out-of-Pocket Costs for Naloxone
JAMA Health Forum
EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, AUGUST 19, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.2663?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081922
About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.
About The Study: In this observational study of nearly 720,000 pharmacy claims data, out-of-pocket cost of naloxone had been an increasingly substantial barrier to naloxone access for uninsured patients, potentially limiting use among this population, which constituted approximately 20% of adults with opioid use disorder.
Authors: Evan D. Peet, Ph.D., of the RAND Corporation in Pittsburgh, is the corresponding author.
(doi:10.1001/jamahealthforum.2022.2663)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Comparing Prevalence of HPV Infection
JAMA Health Forum
EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, AUGUST 19, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.2706?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081922
About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.
About The Study: Researchers compared the prevalence of human papillomavirus (HPV) among women born in the 1980s versus the 1990s and a pre-HPV vaccination period (2005-2006) versus a recent vaccination period (2015-2016).
Authors: Ashish A. Deshmukh, Ph.D., M.P.H., of the University of Texas Health Science Center School of Public Health in Houston, is the corresponding author.
(doi:10.1001/jamahealthforum.2022.2706)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Visual Abstract: Etoposide, Cisplatin vs Irinotecan, Cisplatin for Neuroendocrine Carcinoma of Digestive System
JAMA Oncology
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 18, 2022
Media advisory: The full study is linked to this news release. A visual abstract is below.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.3395?guestAccessKey=686b68ae-7de7-4777-9e3c-13a3fe86deb8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081822
Visual Abstract
Authors: Chigusa Morizane, M.D., Ph.D., of the National Cancer Center Hospital in Tokyo, is the corresponding author.
(doi:10.1001/jamaoncol.2022.3395)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Clinical, Genetic Risk Factors for Acute Incident Venous Thromboembolism in Ambulatory Patients With COVID-19
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2022.3858?guestAccessKey=6ab36e9c-4c33-44db-baae-17531a47d573&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081822
Peripheral Lesions on Ultra-Widefield Imaging, Risk of Diabetic Retinopathy Worsening
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2022.3131?guestAccessKey=a67488ed-c861-4cba-be03-15e63f89594c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081822
Comparing Home- and Clinic-Based Visual Acuity Testing
JAMA Ophthalmology
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 18, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2022.3182?guestAccessKey=14d1b5a9-9e77-474e-b3fe-ffafac5acaa8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081822
About The Study: Researchers compared visual acuity testing at home with visual acuity testing in a clinical setting.
Authors: Michael D. Crossland, Ph.D., of the UCL Institute of Ophthalmology in London, is the corresponding author.
(doi:10.1001/jamaophthalmol.2022.3182)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Incidence of COVID-19 Among People Experiencing Homelessness
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 18, 2022
Media advisory: The full study and commentary are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.27248?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081822
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: The results of this survey of health departments suggest that the annual incidence rate of COVID-19 was lower among people experiencing homelessness than in the general population at state and local levels. A national estimate and the extent of under- or overestimation of the incidence rate remain unknown.
Authors: Ashley A. Meehan, M.P.H., of the Centers for Disease Control and Prevention in Atlanta, is the corresponding author.
(doi:10.1001/jamanetworkopen.2022.27248)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Change in Surgical Volume During COVID-19
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 18, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.27443?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081822
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: This analysis at a large urban hospital found a severe decline in surgical procedure volumes across a multitude of subspecialties during the COVID-19 peak and that after the peak and vaccine release periods the overall volume did not fully recover, with inconsistent recovery rates across subspecialties. Further research and hospital-level changes are needed to address the backlog of surgical services.
Authors: Marc D. Succi, M.D., of Massachusetts General Hospital in Boston, is the corresponding author.
(doi:10.1001/jamanetworkopen.2022.27443)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Examining Family History of Psychiatric Disorders as Risk Factor for Postpartum Depression
JAMA Psychiatry
EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, AUGUST 17, 2022
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2022.2400?guestAccessKey=314a32fe-3233-4ad1-8628-a4916a584ddd&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081722
About The Study: In this systematic review and meta-analysis comprising 26 studies from five continents totaling more than 100,000 women, the risk of developing postpartum depression was almost twice as high among mothers who had a family history of psychiatric disorders compared with mothers without a family history.
Authors: Mette-Marie Zacher Kjeldsen, M.Sc., of Aarhus University in Aarhus, Denmark, is the corresponding author.
(10.1001/jamapsychiatry.2022.2400)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Awareness of SARS-CoV-2 Omicron Variant Infection Among Adults
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, AUGUST 17, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.27241?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081722
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: The results of this study in Los Angeles County of 210 adults with recent Omicron variant infection suggest that more than half were unaware of their infectious status and that awareness was higher among health care employees than nonemployees, yet it was still low overall. Unawareness may be a key contributor to rapid transmission of the virus within communities.
Authors: Susan Cheng, M.D., M.P.H., of Cedars-Sinai Medical Center in Los Angeles, is the corresponding author.
(doi:10.1001/jamanetworkopen.2022.27241)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Estimated Long-Term Effectiveness Among Adolescents of Pfizer-BioNTech COVID-19 Vaccine
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, AUGUST 17, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.27205?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081722
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: Researchers estimated the long-term effectiveness associated with the Pfizer-BioNTech COVID-19 vaccine against SARS-CoV-2 infection and critical infection among 3.2 million adolescents in South Korea.
Authors: Young-Joon Park, M.D., M.P.H., of the Korea Disease Control and Prevention Agency in Cheongju, South Korea, is the corresponding author.
(doi:10.1001/jamanetworkopen.2022.27205)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Visual Abstract: Effectiveness of Commercial Weight Management Program Compared With Do-It-Yourself Approach
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, AUGUST 16, 2022
Media advisory: The full study is linked to this news release. A visual abstract is below.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.26561?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081622
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
Visual Abstract
Authors: Deborah F. Tate, Ph.D., of the University of North Carolina at Chapel Hill, is the corresponding author.
(doi:10.1001/jamanetworkopen.2022.26561)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Funding Sources of Therapeutic, Vaccine Clinical Trials for COVID-19
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, AUGUST 16, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.26892?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081622
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: This analysis of 1,977 clinical trials investigating therapeutics and vaccines for COVID-19 found that most were funded by public sources (58%), followed by industry (27%) and public-private partnerships (15%). Most of these clinical trials focused on COVID-19 therapeutics (85%) as opposed to vaccines (15%).
Authors: Elias Mossialos, Ph.D., of the London School of Economics and Political Science, is the corresponding author.
(doi:10.1001/jamanetworkopen.2022.26892)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Visual Abstract: Remote Ischemic Conditioning vs Usual Care on Neurologic Function in Patients With Acute Moderate Ischemic Stroke
JAMA
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, AUGUST 16, 2022
Media advisory: The full study and editorial are linked to this news release. A visual abstract is below.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.13123?guestAccessKey=17c1312a-023f-46aa-92a4-a0126996ce4e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081622
Visual Abstract
Authors: Hui-Sheng Chen, M.D., of the General Hospital of Northern Theatre Command in Shenyang, China, is the corresponding author.
(doi:10.1001/jama.2022.13123)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Virologic Efficacy of Casirivimab, Imdevimab in Outpatients With SARS-CoV-2 Infection
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.25411?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081522
Association of COVID-19 vs Influenza With Risk of Arterial, Venous Thrombotic Events
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.13072?guestAccessKey=e18656de-3c96-4eec-b3c0-7832382043cc&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081622
Visual Abstract: Standard vs Enhanced Self-Measurement of Blood Pressure Paired With Smartphone Application
JAMA Internal Medicine
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, AUGUST 15, 2022
Media advisory: The full study is linked to this news release. A visual abstract is below.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2022.3355?guestAccessKey=fd9d8a9c-2d02-4b28-9e0d-0e4b4c9afdf9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081522
Visual Abstract
Authors: Mark J. Pletcher, M.D., M.P.H., of the University of California, San Francisco, is the corresponding author.
(doi:10.1001/jamainternmed.2022.3355)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Association of Methamphetamine, Opioid Use With Nonfatal Overdose in Rural Communities
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, AUGUST 15, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.26544?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081522
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: In this study of rural communities in 10 states, 79% of people using drugs reported past-30-day methamphetamine use. Nonfatal overdose was greatest in people using both methamphetamine and opioids vs opioids or methamphetamine alone. People using both substances reported the least access to treatment. These findings suggest that harm reduction and substance use disorder treatment interventions must address methamphetamine use as well as opioids to decrease overdose in rural communities.
Authors: P. Todd Korthuis, M.D., M.P.H., of Oregon Health & Science University in Portland, is the corresponding author.
(doi:10.1001/jamanetworkopen.2022.26544)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Racial, Sex Disparities of Gout
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, AUGUST 15, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.26804?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081522
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: Gout was more common in adults self-reporting Black race during a recent 10-year period compared with their white counterparts in this nationally representative study. These racial differences may be explained by sex-specific differences in diet and social determinants of health and clinical factors. Culturally informed efforts focusing on these factors could reduce current gout-related disparities.
Authors: Natalie McCormick, Ph.D., of Massachusetts General Hospital in Boston, is the corresponding author.
(doi:10.1001/jamanetworkopen.2022.26804)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Comparison of Electric Scooter, Bicycle Injuries
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, AUGUST 15, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.26701?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081522
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: In this study of nearly 3,200 individuals who were injured while using electric scooters or bicycles in Oslo, Norway, electric scooter riders, compared with bicyclists, were younger, less frequently wearing a helmet, more often intoxicated and were more often injured at night. The rate of intoxication among electric scooter riders injured at night was high. Preventive measures, including awareness campaigns, regulating electric scooter availability, improving infrastructure, and implementing stricter helmet and alcohol policies, may prove effective for reducing injuries.
Authors: August Vincent Stray, M.D., D.D.S., of Oslo University Hospital in Oslo, Norway, is the corresponding author.
(doi:10.1001/jamanetworkopen.2022.26701)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Risk of SARS-CoV-2 Among Health Care Workers According to Patient Exposure, Mask Type
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, AUGUST 15, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.26816?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081522
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: Researchers compared the risk of infection with SARS-CoV-2 among 2,900 health care workers by preferred mask type and level of exposure to patients with COVID-19.
Authors: Philipp Kohler, M.D., M.Sc., of Cantonal Hospital St. Gallen in St. Gallen, Switzerland, is the corresponding author.
(doi:10.1001/jamanetworkopen.2022.26816)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Severe Maternal Morbidities Associated With Specific SARS-CoV-2 Variants
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.26436?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081222
Association Between Relaxation of Public Health Measures, Transmission of COVID-19 Omicron Variant in South Korea
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.25665?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081222
Changes in Migration, Mortality Among Patients With Kidney Failure in Puerto Rico After Hurricane Maria
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.2534?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081222
About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.
Trends in the Source of New Enrollees to Medicare Advantage
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.2585?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081222
About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.
Tolerability of COVID-19 Infection, mRNA Vaccination Among Patients With Kawasaki Disease
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.26236?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081222
Health Care Use Following SARS-CoV-2 Infection
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, AUGUST 12, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.25657?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081222
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: Among 127,000 patients with a positive SARS-CoV-2 test, health care use was elevated six months after the acute infection compared with patients with negative SARS-CoV-2 test results. These findings suggest that health care systems should consider long-term strategic resource allocation in response to the expected elevated health care use experienced by patients with SARS-CoV-2 infection.
Authors: Sara Y. Tartof, Ph.D., M.P.H., of Kaiser Permanente Southern California in Pasadena, is the corresponding author.
(doi:10.1001/jamanetworkopen.2022.25657)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Comparing Pregnancy, Birth Outcomes Before vs During Pandemic
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, AUGUST 12, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.26531?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081222
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: During the first 14 months of the COVID-19 pandemic there were small but significant increases in pregnancy-related complications and maternal death during delivery hospitalization in this study of more than 1.6 million pregnant patients across 463 hospitals. The number of live births decreased by 5.2%. Further efforts are needed to ensure risks potentially associated with the COVID-19 pandemic do not persist beyond the current state of the pandemic.
Authors: Rose L. Molina, M.D., M.P.H., of the Beth Israel Deaconess Medical Center in Boston, is the corresponding author.
(doi:10.1001/jamanetworkopen.2022.26531)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Association of Direct-to-Consumer Advertising of Prescription Drugs With Consumer Health-Related Intentions, Beliefs
JAMA Health Forum
EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, AUGUST 12, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.2570?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081222
About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.
About The Study: Researchers examined the association of direct-to-consumer advertising of prescription drugs with consumer intentions and beliefs related to prescription drugs and health-related behaviors in this study that included 2,874 individuals at risk of cardiovascular disease.
Authors: Matthew D. Eisenberg, Ph.D., of the Johns Hopkins Bloomberg School of Public Health in Baltimore, is the corresponding author.
(doi:10.1001/jamahealthforum.2022.2570)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Antibody Response of 3-Dose COVID-19 Vaccination Schedule in Immunocompromised Patients With Hematologic Cancers
JAMA Oncology
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 11, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.3227?guestAccessKey=0b9a95d7-73d1-49c0-a5a8-c690dae47ecc&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081122
About The Study: In this study that included 584 immunocompromised patients with hematologic cancers, a third Moderna COVID-19 vaccination was associated with significantly improved SARS-CoV-2 antibody concentrations comparable to those obtained by healthy individuals after the standard two-dose Moderna vaccination schedule.
Authors: Mette D. Hazenberg, M.D., Ph.D., of the University of Amsterdam, is the corresponding author.
(doi:10.1001/jamaoncol.2022.3227)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
COVID-19 Vaccination Rates Among Adults With Vision, Hearing Disabilities
JAMA Ophthalmology
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 11, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2022.3041?guestAccessKey=2c78daf0-21f0-49cb-b022-129bc31b2cab&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081122
About The Study: The findings of this survey study suggest that COVID-19 vaccine initiation is lower among adults with vision or hearing disabilities compared with adults without disabilities. This information may inform initiatives to promote equitable and accessible vaccination.
Authors: Kea Turner, Ph.D., M.P.H., M.A., of the Moffitt Cancer Center in Tampa, Florida, is the corresponding author.
(doi:10.1001/jamaophthalmol.2022.3041)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Visual Abstract: Effect of Etomidate vs Propofol on Postoperative Complications in Older Patients
JAMA Surgery
EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, AUGUST 10, 2022
Media advisory: The full study and commentary are linked to this news release. A visual abstract is below.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2022.3338?guestAccessKey=b9343f2e-87ef-4a93-81d1-3ad8ecb69f4d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081022
Visual Abstract
Authors: Lize Xiong, M.D., Ph.D., of the Shanghai Fourth People’s Hospital Affiliated to Tongji University School of Medicine in Shanghai, and Hailong Dong, M.D., Ph.D., of the Fourth Military Medical University in Xi’an, China, are the corresponding authors.
(doi:10.1001/jamasurg.2022.3338)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Visual Abstract: Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart Failure
JAMA Cardiology
EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, AUGUST 10, 2022
Media advisory: The full study and commentary are linked to this news release. A visual abstract is below.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2022.2496?guestAccessKey=41a1bc2f-4063-4f33-8fb5-858f0c57420e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081022
Visual Abstract
Authors: Tariq Ahmad, M.D., M.P.H., of the Yale University School of Medicine in NewHaven, Connecticut, is the corresponding author.
(doi:10.1001/jamacardio.2022.2496)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Visual Abstract: Effect of Decision Aid on Agreement Between Patient Preferences, Repair Type for Abdominal Aortic Aneurysm
JAMA Surgery
EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, AUGUST 10, 2022
Media advisory: The full study and commentary are linked to this news release. A visual abstract is below.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2022.2935?guestAccessKey=7e9942e4-152d-40d9-98f3-825a8814887e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081022
Visual Abstract
Authors: Philip P. Goodney, M.D., M.S., of the White River Junction VA Medical Center in White River Junction, Vermont, is the corresponding author.
(doi:10.1001/jamasurg.2022.2935)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Examining Immune Response of ‘Mix-and-Match’ Booster
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, AUGUST 10, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.26335?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081022
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: This study of 68 adults who originally received the Pfizer-BioNTech COVID-19 vaccine found that being boosted with either the Janssen or Pfizer-BioNTech vaccine was associated with increased humoral and cellular immune responses. Boosting with the Janssen vaccine was associated with durable antibody and T-cell responses for at least four months.
Authors: Dan H. Barouch, M.D., Ph.D., of Beth Israel Deaconess Medical Center in Boston, is the corresponding author.
(doi:10.1001/jamanetworkopen.2022.26335)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Assessing Outcomes of Flexible Boosting of CoronaVac COVID-19 Vaccine
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, AUGUST 10, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.26046?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081022
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: In this study using national data of nearly 14 million vaccinated individuals in Malaysia, researchers assessed the risk of symptomatic SARS-CoV-2 infection associated with two doses of the CoronaVac (Sinovac Biotech) COVID-19 vaccine plus a third dose or a Pfizer-BioNTech booster compared with two or three doses of the Pfizer-BioNTech vaccine.
Authors: Ee Vien Low, Ph.D., of the Ministry of Health Malaysia in Shah Alam, Malaysia, is the corresponding author.
(doi:10.1001/jamanetworkopen.2022.26046)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Visual Abstract: Effect of Adjunctive Acupuncture on Pain Relief Among Patients With Acute Renal Colic
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, AUGUST 9, 2022
Media advisory: The full study is linked to this news release. A visual abstract is below.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.25735?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=080922
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
Visual Abstract
Authors: Cun-Zhi Liu, M.D., Ph.D., of Beijing University of Chinese Medicine in Beijing, and Zhi-Cheng Qu, M.D., Ph.D., of Capital Medical University in Beijing, are the corresponding authors.
(doi:10.1001/jamanetworkopen.2022.25735)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Visual Abstract: Dexmedetomidine or Midazolam to Prevent Perioperative Respiratory Adverse Events in Children Undergoing Tonsillectomy, Adenoidectomy
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, AUGUST 9, 2022
Media advisory: The full study and commentary are linked to this news release. A visual abstract is below.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.25473?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=080922
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
Visual Abstract
Authors: He Liu, Ph.D., of Huzhou Central Hospital in Huzhou, Zhejiang, China, and Yueying Zhang, M.D., of the Affiliated Hospital of Xuzhou Medical University in Xuzhou, Jiangsu, China, are the corresponding authors.
(doi:10.1001/jamanetworkopen.2022.25473)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Visual Abstract: Effect of Peer-Led Behavioral Intervention for Patients at High Risk of Fatal Opioid Overdose
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, AUGUST 9, 2022
Media advisory: The full study is linked to this news release. A visual abstract is below.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.25582?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=080922
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
Visual Abstract
Authors: Francesca L. Beaudoin, M.D., Ph.D., of the Brown University School of Public Health in Providence, Rhode Island, is the corresponding author.
(doi:10.1001/jamanetworkopen.2022.25582)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Levodopa Content of Mucuna pruriens Supplements in NIH Dietary Supplement Label Database
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2022.2184?guestAccessKey=29c10e65-bb81-4104-8bcb-ee93603f296e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=080822
Visual Abstract: Effect of Stenting Plus Medical Therapy vs Medical Therapy Alone on Risk of Stroke, Death in Intracranial Stenosis
JAMA
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, AUGUST 9, 2022
Media advisory: The full study and editorial are linked to this news release. A visual abstract is below.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.12000?guestAccessKey=ac19d759-006b-41d5-8cd5-8bd2c8536955&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=080922
Visual Abstract
Authors: Liqun Jiao, M.D., of Capital Medical University in Beijing, is the corresponding author.
(doi:10.1001/jama.2022.12000)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Visual Abstract: Effect of Intravenous Tirofiban vs Placebo Before Endovascular Thrombectomy for Ischemic Stroke
JAMA
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, AUGUST 9, 2022
Media advisory: The full study and editorial are linked to this news release. A visual abstract is below.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.12584?guestAccessKey=13931378-98ba-4ad6-9025-3384c114da83&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=080922
Visual Abstract
Authors: Qingwu Yang, M.D., Ph.D., and Wenjie Zi, M.D., of the Army Medical University in Chongqing, China, are the corresponding authors.
(doi:10.1001/jama.2022.12584)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Visual Abstract: Effectiveness of Early Time-Restricted Eating for Weight Loss in Adults With Obesity
JAMA Internal Medicine
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, AUGUST 8, 2022
Media advisory: The full study and commentary are linked to this news release. A visual abstract is below.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2022.3050?guestAccessKey=7bd58555-686e-4f5c-a08f-7c021e6c1029&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=080822
Visual Abstract
Authors: Courtney M. Peterson, Ph.D., of the University of Alabama at Birmingham, is the corresponding author.
(doi:10.1001/jamainternmed.2022.3050)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Visual Abstract: Patient-Centered Pain Care Using Artificial Intelligence, Mobile Health Tools for Chronic Back Pain
JAMA Internal Medicine
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, AUGUST 8, 2022
Media advisory: The full study is linked to this news release. A visual abstract is below.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2022.3178?guestAccessKey=370655a5-479a-49ee-ab36-fb39f67b9949&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=080822
Visual Abstract
Authors: John D. Piette, M.Sc., Ph.D., of the University of Michigan School of Public Health in Ann Arbor, is the corresponding author.
(doi:10.1001/jamainternmed.2022.3178)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Global Prevalence, Incidence of Tinnitus
JAMA Neurology
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, AUGUST 8, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2022.2189?guestAccessKey=ef890f95-7a23-4c1f-b694-7c20dcf79df6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=080822
About The Study: Tinnitus affects more than 740 million adults globally and is perceived as a major problem by more than 120 million people, according to the results of this systematic review and meta-analysis.
Authors: Silvano Gallus, Ph.D., of Istituto di Ricerche Farmacologiche Mario Negri IRCCS in Milan, Italy, is the corresponding author.
(doi:10.1001/jamaneurol.2022.2189)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Ten-Year Sales Trends of Alzheimer Disease Drugs in France Compared With Germany, Spain, UK
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.2253?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=080522
About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.
Examining SARS-CoV-2 In-Class Transmission at a Large Urban University With Public Health Mandates
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, AUGUST 5, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.25430?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=080522
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
About The Study: The results of this study of 140,000 class meetings suggest that in-class transmission of SAR-CoV-2 in an urban university with masking and vaccine protocols in-place was negligible.
Authors: Hannah E. Landsberg, M.S.N., M.P.H., of Boston University, is the corresponding author.
(doi:10.1001/jamanetworkopen.2022.25430)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Cost-effectiveness of Screening for Atrial Fibrillation Using Wearable Devices
JAMA Health Forum
EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, AUGUST 5, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.2419?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=080522
About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.
About The Study: Researchers evaluated the cost-effectiveness of contemporary atrial fibrillation screening strategies, particularly wrist-worn wearable devices, in this simulation study.
Authors: Jagpreet Chhatwal, Ph.D., of Massachusetts General Hospital in Boston, is the corresponding author.
(doi:10.1001/jamahealthforum.2022.2419)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Association Between State Opioid Prescribing Cap Laws, Opioid Prescriptions Among Children, Adolescents
JAMA Health Forum
EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, AUGUST 5, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.2461?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=080522
About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.
About The Study: In this study of 482,000 children and adolescents, no association was found between state laws limiting dose or duration, or both, in opioid prescriptions and the receipt of opioid prescriptions among children and adolescents. Alternative strategies, such as opioid prescribing guidelines tailored to youths, are needed.
Authors: Elizabeth Stone, M.S.P.H., of the Johns Hopkins Bloomberg School of Public Health in Baltimore, is the corresponding author.
(doi:10.1001/jamahealthforum.2022.2461)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Role of Military Forces in New York State Response to COVID-19
JAMA Health Forum
EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, AUGUST 5, 2022
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.2136?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=080522
About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.
About The Article: The role of New York State military forces in responding to the COVID-19 pandemic was examined in this article.
Authors: Kai Ruggeri, Ph.D., of Columbia University in New York, is the corresponding author.
(doi:10.1001/jamahealthforum.2022.2136)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.